TriSalus Life Sciences (TLSI) Cash from Investing Activities (2022 - 2026)
TriSalus Life Sciences (TLSI) posted quarterly Cash from Investing Activities of -$141000.0 for Q1 2026, up 80.25% year-over-year from -$78223.8 in Q1 2025, and down 243.9% quarter-over-quarter from -$41000.0 in Q4 2025.
TriSalus Life Sciences (TLSI) Cash from Investing Activities (2022 - 2026) Analysis & Trends
TriSalus Life Sciences' Cash from Investing Activities history runs 5 years deep, the most recent figure standing at -$141000.0 for Q1 2026.
- In Q1 2026, Cash from Investing Activities rose 80.25% year-over-year to -$141000.0; the TTM figure through Mar 2026 stood at -$265000.0 (up 73.31% YoY), while the FY2025 annual figure was -$838000.0, down 142.9% from the prior year.
- Cash from Investing Activities for Q1 2026 stood at -$141000.0, down from -$41000.0 in the prior quarter.
- The five-year high for Cash from Investing Activities was $93000.0 in Q2 2025, with the low at -$1.6 million in Q3 2022.
- The 5-year median for Cash from Investing Activities is -$74000.0 (2023), against an average of -$276352.9.
- Peak annual rise in Cash from Investing Activities reached 255.0% in 2025, while the deepest fall reached 981.82% in 2025.
- TriSalus Life Sciences' Cash from Investing Activities stood at -$272000.0 in 2022, then slumped by 36.76% to -$372000.0 in 2023, then soared by 86.56% to -$50000.0 in 2024, then advanced by 18.0% to -$41000.0 in 2025, then sank by 243.9% to -$141000.0 in 2026.
- Business Quant data shows TLSI's Cash from Investing Activities at -$141000.0 in Q1 2026, -$41000.0 in Q4 2025, and -$176000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | -673.00 Mn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | -639.00 Mn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | -917.00 Mn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | -1.96 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | -193.20 Mn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 329.80 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | -115.00 Mn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | -22.08 Mn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | -108.50 Mn |
| 10 | TriSalus Life Sciences | 307.22 Mn | 260.94 Mn | 9.90 Mn | -82,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -82,000.00 |
| Jun 30, 2026 | -82,000.00 |
| Mar 31, 2026 | -141,000.00 |
| Mar 31, 2026 | -141,000.00 |
| Dec 31, 2025 | -41,000.00 |
| Dec 31, 2025 | -41,000.00 |
| Sep 30, 2025 | -176,000.00 |
| Sep 30, 2025 | -176,000.00 |
| Jun 30, 2025 | 93,000.00 |
| Jun 30, 2025 | 93,000.00 |
| Mar 31, 2025 | -714,000.00 |
| Mar 31, 2025 | -714,000.00 |
| Dec 31, 2024 | -50,000.00 |
| Dec 31, 2024 | -50,000.00 |
| Sep 30, 2024 | -169,000.00 |
| Sep 30, 2024 | -169,000.00 |
| Jun 30, 2024 | -60,000.00 |
| Jun 30, 2024 | -60,000.00 |
| Mar 31, 2024 | -66,000.00 |
| Mar 31, 2024 | -66,000.00 |